# A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)

> **NCT00765206** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 60 (actual)

## Conditions studied

- Gastric Acid
- Human Experimentation

## Interventions

- **DRUG:** Omeprazole/sodium bicarbonate
- **DRUG:** omeprazole magnesium (20 mg equivalent)

## Key facts

- **NCT ID:** NCT00765206
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765206, "A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00765206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*